Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

GammaDelta Therapeutics Spins Out Adaptate Biotherapeutics (2019-10-16)
GammaDelta Therapeutics spins-out new company to accelerate antibody-based assets towards clinical studies GammaDelta Therapeutics, a company focussed on harnessing the unique properties of gamma delta (gd) T-cells to develop transformational immunotherapies, ...
Healx Ltd Secures $56m Series B Round Led by Atomico (2019-10-16)
Latest round of funding, led by Atomico, will be used to build a clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism. Healx’s Rare Treatment Accelerator programme is a new initiative launched ...
Amarna Raises €10m Round to Advance Gene Therapy into Clinic (2019-10-16)
> Round led by Swedish investor Flerie Invest AB with substantial contributions from the Netherlands Enterprise Agency and existing shareholders > Appoints a new Supervisory Board with six highly experienced individuals > Start of first-in-man phase I/II clin...
Abalos Therapeutics Launches with €12M Series A Round (2019-10-15)
-- Dr. Marcus Kostka appointed CEO, Dr. Jörg Vollmer joins as CSO -- Abalos Therapeutics announced today a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutic...
Gilead Sciences Appoints Andrew Dickinson as CFO (2019-10-15)
Gilead Sciences, Inc. (NASDAQ: GILD) today announced that Andrew Dickinson has been appointed Chief Financial Officer (CFO), effective November 1. Mr. Dickinson currently serves as the company’s Executive Vice President, Corporate Development and Strategy, and in h...
CRISPR Therapeutics & KSQ Therapeutics: License Agreement (2019-10-15)
- CRISPR Therapeutics to receive non-exclusive access to certain KSQ IP for its allogeneic CAR-T programs - - KSQ Therapeutics to receive non-exclusive access to certain CRISPR IP for its autologous cell therapies, including its existing eTIL™ cell franchise - ...
Numab Appoints Daniel Vasella to Board of Directors (2019-10-15)
Numab Therapeutics AG today announced that effective October 1 it has appointed former Novartis CEO and Chairman Dr. Daniel Vasella to its Board of Directors. Dr. David Urech, CEO of Numab, said: “We are delighted to welcome Daniel Vasella to our Board of Dir...
Mogrify Raises $16m in First Close of Series A Round (2019-10-14)
> Initial close of Series A funding brings the total raised to over $20 million to date > Funding will accelerate Mogrify’s internal cell therapy programs, and the development and out-license of novel IP relating to cell conversions of broad therapeutic interest...
UCB to Acquire Ra Pharmaceuticals for €2b Net of Cash (2019-10-10)
> Will enhance UCB’s leadership potential in myasthenia gravis by adding zilucoplan, a peptide inhibitor of complement component 5 (C5) currently in phase 3, to the UCB pipeline alongside to UCB’s rozanolixizumab, an FcRn targeting antibody also in phase 3 > Wil...
BioNtech Prices $150m US IPO at Nasdaq at $15 per ADS (2019-10-10)
BioNTech SE (“BioNTech”), a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, today announced the pricing of its initial public offering of 10,000,000 American Depositary Shares ...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]